OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of change from suvorexant to lemborexant drug in the treatment of sleep disorders
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 595-604
Closed Access | Times Cited: 7
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 595-604
Closed Access | Times Cited: 7
Showing 7 citing articles:
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study
Motohiro Ozone, Susumu Hirota, Yu Ariyoshi, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1728-1745
Open Access | Times Cited: 7
Motohiro Ozone, Susumu Hirota, Yu Ariyoshi, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1728-1745
Open Access | Times Cited: 7
Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study
Ryozo Yoshioka, Seiichiro Yamamoto, Eiji Nakatani
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284726-e0284726
Open Access | Times Cited: 5
Ryozo Yoshioka, Seiichiro Yamamoto, Eiji Nakatani
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284726-e0284726
Open Access | Times Cited: 5
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant
Kazumaro Okino, Hirohisa Suzuki, Hiroi Tomioka, et al.
Human Psychopharmacology Clinical and Experimental (2023) Vol. 38, Iss. 3
Closed Access | Times Cited: 4
Kazumaro Okino, Hirohisa Suzuki, Hiroi Tomioka, et al.
Human Psychopharmacology Clinical and Experimental (2023) Vol. 38, Iss. 3
Closed Access | Times Cited: 4
Safety and real-world efficacy of lemborexant in the treatment of comorbid insomnia
Narimasa Katsuta, Keitaro Takahashi, Yui Kurosawa, et al.
Sleep Medicine X (2023) Vol. 5, pp. 100070-100070
Open Access | Times Cited: 2
Narimasa Katsuta, Keitaro Takahashi, Yui Kurosawa, et al.
Sleep Medicine X (2023) Vol. 5, pp. 100070-100070
Open Access | Times Cited: 2
Short-Term Efficacy and Safety of Suvorexant and Lemborexant: A Retrospective Study
Koki Mori, M Kimura, Eiseki Usami
Cureus (2024)
Open Access
Koki Mori, M Kimura, Eiseki Usami
Cureus (2024)
Open Access
Evaluation of prescribing patterns of switching to and add-on lemborexant in patients treated with hypnotic medication: a nationwide claims database study in Japan
Sachiko Tanaka‐Mizuno, Kenichi Fujimoto, Kazuo Mishima, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 12, pp. 1707-1716
Open Access
Sachiko Tanaka‐Mizuno, Kenichi Fujimoto, Kazuo Mishima, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 12, pp. 1707-1716
Open Access
Comparative efficacy and safety of suvorexant and lemborexant for insomnia treatment
Teruaki Hayashi, Takehiko Yamanashi, Masaaki Iwata
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Teruaki Hayashi, Takehiko Yamanashi, Masaaki Iwata
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 1
